BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2437 related articles for article (PubMed ID: 34351721)

  • 1. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
    ; ; ; Lawler PR; Goligher EC; Berger JS; Neal MD; McVerry BJ; Nicolau JC; Gong MN; Carrier M; Rosenson RS; Reynolds HR; Turgeon AF; Escobedo J; Huang DT; Bradbury CA; Houston BL; Kornblith LZ; Kumar A; Kahn SR; Cushman M; McQuilten Z; Slutsky AS; Kim KS; Gordon AC; Kirwan BA; Brooks MM; Higgins AM; Lewis RJ; Lorenzi E; Berry SM; Berry LR; Aday AW; Al-Beidh F; Annane D; Arabi YM; Aryal D; Baumann Kreuziger L; Beane A; Bhimani Z; Bihari S; Billett HH; Bond L; Bonten M; Brunkhorst F; Buxton M; Buzgau A; Castellucci LA; Chekuri S; Chen JT; Cheng AC; Chkhikvadze T; Coiffard B; Costantini TW; de Brouwer S; Derde LPG; Detry MA; Duggal A; Džavík V; Effron MB; Estcourt LJ; Everett BM; Fergusson DA; Fitzgerald M; Fowler RA; Galanaud JP; Galen BT; Gandotra S; García-Madrona S; Girard TD; Godoy LC; Goodman AL; Goossens H; Green C; Greenstein YY; Gross PL; Hamburg NM; Haniffa R; Hanna G; Hanna N; Hegde SM; Hendrickson CM; Hite RD; Hindenburg AA; Hope AA; Horowitz JM; Horvat CM; Hudock K; Hunt BJ; Husain M; Hyzy RC; Iyer VN; Jacobson JR; Jayakumar D; Keller NM; Khan A; Kim Y; Kindzelski AL; King AJ; Knudson MM; Kornblith AE; Krishnan V; Kutcher ME; Laffan MA; Lamontagne F; Le Gal G; Leeper CM; Leifer ES; Lim G; Lima FG; Linstrum K; Litton E; Lopez-Sendon J; Lopez-Sendon Moreno JL; Lother SA; Malhotra S; Marcos M; Saud Marinez A; Marshall JC; Marten N; Matthay MA; McAuley DF; McDonald EG; McGlothlin A; McGuinness SP; Middeldorp S; Montgomery SK; Moore SC; Morillo Guerrero R; Mouncey PR; Murthy S; Nair GB; Nair R; Nichol AD; Nunez-Garcia B; Pandey A; Park PK; Parke RL; Parker JC; Parnia S; Paul JD; Pérez González YS; Pompilio M; Prekker ME; Quigley JG; Rost NS; Rowan K; Santos FO; Santos M; Olombrada Santos M; Satterwhite L; Saunders CT; Schutgens REG; Seymour CW; Siegal DM; Silva DG; Shankar-Hari M; Sheehan JP; Singhal AB; Solvason D; Stanworth SJ; Tritschler T; Turner AM; van Bentum-Puijk W; van de Veerdonk FL; van Diepen S; Vazquez-Grande G; Wahid L; Wareham V; Wells BJ; Widmer RJ; Wilson JG; Yuriditsky E; Zampieri FG; Angus DC; McArthur CJ; Webb SA; Farkouh ME; Hochman JS; Zarychanski R
    N Engl J Med; 2021 Aug; 385(9):790-802. PubMed ID: 34351721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
    ; ; ; Goligher EC; Bradbury CA; McVerry BJ; Lawler PR; Berger JS; Gong MN; Carrier M; Reynolds HR; Kumar A; Turgeon AF; Kornblith LZ; Kahn SR; Marshall JC; Kim KS; Houston BL; Derde LPG; Cushman M; Tritschler T; Angus DC; Godoy LC; McQuilten Z; Kirwan BA; Farkouh ME; Brooks MM; Lewis RJ; Berry LR; Lorenzi E; Gordon AC; Ahuja T; Al-Beidh F; Annane D; Arabi YM; Aryal D; Baumann Kreuziger L; Beane A; Bhimani Z; Bihari S; Billett HH; Bond L; Bonten M; Brunkhorst F; Buxton M; Buzgau A; Castellucci LA; Chekuri S; Chen JT; Cheng AC; Chkhikvadze T; Coiffard B; Contreras A; Costantini TW; de Brouwer S; Detry MA; Duggal A; Džavík V; Effron MB; Eng HF; Escobedo J; Estcourt LJ; Everett BM; Fergusson DA; Fitzgerald M; Fowler RA; Froess JD; Fu Z; Galanaud JP; Galen BT; Gandotra S; Girard TD; Goodman AL; Goossens H; Green C; Greenstein YY; Gross PL; Haniffa R; Hegde SM; Hendrickson CM; Higgins AM; Hindenburg AA; Hope AA; Horowitz JM; Horvat CM; Huang DT; Hudock K; Hunt BJ; Husain M; Hyzy RC; Jacobson JR; Jayakumar D; Keller NM; Khan A; Kim Y; Kindzelski A; King AJ; Knudson MM; Kornblith AE; Kutcher ME; Laffan MA; Lamontagne F; Le Gal G; Leeper CM; Leifer ES; Lim G; Gallego Lima F; Linstrum K; Litton E; Lopez-Sendon J; Lother SA; Marten N; Saud Marinez A; Martinez M; Mateos Garcia E; Mavromichalis S; McAuley DF; McDonald EG; McGlothlin A; McGuinness SP; Middeldorp S; Montgomery SK; Mouncey PR; Murthy S; Nair GB; Nair R; Nichol AD; Nicolau JC; Nunez-Garcia B; Park JJ; Park PK; Parke RL; Parker JC; Parnia S; Paul JD; Pompilio M; Quigley JG; Rosenson RS; Rost NS; Rowan K; Santos FO; Santos M; Santos MO; Satterwhite L; Saunders CT; Schreiber J; Schutgens REG; Seymour CW; Siegal DM; Silva DG; Singhal AB; Slutsky AS; Solvason D; Stanworth SJ; Turner AM; van Bentum-Puijk W; van de Veerdonk FL; van Diepen S; Vazquez-Grande G; Wahid L; Wareham V; Widmer RJ; Wilson JG; Yuriditsky E; Zhong Y; Berry SM; McArthur CJ; Neal MD; Hochman JS; Webb SA; Zarychanski R
    N Engl J Med; 2021 Aug; 385(9):777-789. PubMed ID: 34351722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
    Berger JS; Kornblith LZ; Gong MN; Reynolds HR; Cushman M; Cheng Y; McVerry BJ; Kim KS; Lopes RD; Atassi B; Berry S; Bochicchio G; de Oliveira Antunes M; Farkouh ME; Greenstein Y; Hade EM; Hudock K; Hyzy R; Khatri P; Kindzelski A; Kirwan BA; Baumann Kreuziger L; Lawler PR; Leifer E; Lopez-Sendon Moreno J; Lopez-Sendon J; Luther JF; Nigro Maia L; Quigley J; Sherwin R; Wahid L; Wilson J; Hochman JS; Neal MD;
    JAMA; 2022 Jan; 327(3):227-236. PubMed ID: 35040887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.
    Goligher EC; Lawler PR; Jensen TP; Talisa V; Berry LR; Lorenzi E; McVerry BJ; Chang CH; Leifer E; Bradbury C; Berger J; Hunt BJ; Castellucci LA; Kornblith LZ; Gordon AC; McArthur C; Webb S; Hochman J; Neal MD; Zarychanski R; Berry S; Angus DC;
    JAMA; 2023 Apr; 329(13):1066-1077. PubMed ID: 36942550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trial.
    Smilowitz NR; Hade EM; Kornblith LZ; Castellucci LA; Cushman M; Farkouh M; Gong MN; Heath A; Hunt BJ; Kim KS; Kindzelski A; Lawler P; Leaf DE; Goligher E; Leifer ES; McVerry BJ; Reynolds HR; Zarychanski R; Hochman JS; Neal MD; Berger JS
    Res Pract Thromb Haemost; 2023 Aug; 7(6):102167. PubMed ID: 37727846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
    ; Bradbury CA; Lawler PR; Stanworth SJ; McVerry BJ; McQuilten Z; Higgins AM; Mouncey PR; Al-Beidh F; Rowan KM; Berry LR; Lorenzi E; Zarychanski R; Arabi YM; Annane D; Beane A; van Bentum-Puijk W; Bhimani Z; Bihari S; Bonten MJM; Brunkhorst FM; Buzgau A; Buxton M; Carrier M; Cheng AC; Cove M; Detry MA; Estcourt LJ; Fitzgerald M; Girard TD; Goligher EC; Goossens H; Haniffa R; Hills T; Huang DT; Horvat CM; Hunt BJ; Ichihara N; Lamontagne F; Leavis HL; Linstrum KM; Litton E; Marshall JC; McAuley DF; McGlothlin A; McGuinness SP; Middeldorp S; Montgomery SK; Morpeth SC; Murthy S; Neal MD; Nichol AD; Parke RL; Parker JC; Reyes LF; Saito H; Santos MS; Saunders CT; Serpa-Neto A; Seymour CW; Shankar-Hari M; Singh V; Tolppa T; Turgeon AF; Turner AM; van de Veerdonk FL; Green C; Lewis RJ; Angus DC; McArthur CJ; Berry S; Derde LPG; Webb SA; Gordon AC
    JAMA; 2022 Apr; 327(13):1247-1259. PubMed ID: 35315874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial.
    Berger JS; Neal MD; Kornblith LZ; Gong MN; Reynolds HR; Cushman M; Althouse AD; Lawler PR; McVerry BJ; Kim KS; Baumann Kreuziger L; Solomon SD; Kosiborod MN; Berry SM; Bochicchio GV; Contoli M; Farkouh ME; Froess JD; Gandotra S; Greenstein Y; Hade EM; Hanna N; Hudock K; Hyzy RC; Ibáñez Estéllez F; Iovine N; Khanna AK; Khatri P; Kirwan BA; Kutcher ME; Leifer E; Lim G; Lopes RD; Lopez-Sendon JL; Luther JF; Nigro Maia L; Quigley JG; Wahid L; Wilson JG; Zarychanski R; Kindzelski A; Geraci MW; Hochman JS;
    JAMA Netw Open; 2023 May; 6(5):e2314428. PubMed ID: 37227729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic-dose anticoagulation or thromboprophylaxis with low-molecular-weight heparin for moderate Covid-19: meta-analysis of randomized controlled trials.
    Ena J; Valls V
    Clin Exp Med; 2023 Aug; 23(4):1189-1196. PubMed ID: 36048371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.
    Lopes RD; de Barros E Silva PGM; Furtado RHM; Macedo AVS; Bronhara B; Damiani LP; Barbosa LM; de Aveiro Morata J; Ramacciotti E; de Aquino Martins P; de Oliveira AL; Nunes VS; Ritt LEF; Rocha AT; Tramujas L; Santos SV; Diaz DRA; Viana LS; Melro LMG; de Alcântara Chaud MS; Figueiredo EL; Neuenschwander FC; Dracoulakis MDA; Lima RGSD; de Souza Dantas VC; Fernandes ACS; Gebara OCE; Hernandes ME; Queiroz DAR; Veiga VC; Canesin MF; de Faria LM; Feitosa-Filho GS; Gazzana MB; Liporace IL; de Oliveira Twardowsky A; Maia LN; Machado FR; de Matos Soeiro A; Conceição-Souza GE; Armaganijan L; Guimarães PO; Rosa RG; Azevedo LCP; Alexander JH; Avezum A; Cavalcanti AB; Berwanger O;
    Lancet; 2021 Jun; 397(10291):2253-2263. PubMed ID: 34097856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial.
    Houston BL; Lawler PR; Goligher EC; Farkouh ME; Bradbury C; Carrier M; Dzavik V; Fergusson DA; Fowler RA; Galanaud JP; Gross PL; McDonald EG; Husain M; Kahn SR; Kumar A; Marshall J; Murthy S; Slutsky AS; Turgeon AF; Berry SM; Rosenson RS; Escobedo J; Nicolau JC; Bond L; Kirwan BA; de Brouwer S; Zarychanski R
    Clin Trials; 2020 Oct; 17(5):491-500. PubMed ID: 32815416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation as a therapeutic strategy for hospitalised patients with COVID-19.
    Cullivan S; Sholzberg M; Áinle FN; Kevane B
    Thromb Update; 2022 Mar; 6():100097. PubMed ID: 38620689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cov-hep study: heparin in standard anticoagulation based on citrate for continuous veno-venous hemodialysis in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
    Lins PRG; de Albuquerque CCC; Assis CF; Rodrigues BCD; E Siqueira Campos BP; de Oliveira Valle E; Cabrera CPS; de Oliveira Gois J; Segura GC; Strufaldi FL; Mainardes LC; Ribeiro RG; Via Reque Cortes DDP; Lutf LG; de Oliveira MFA; Sales GTM; Smolentzov I; Reichert BV; Andrade L; Seabra VF; Rodrigues CE
    Trials; 2020 Nov; 21(1):920. PubMed ID: 33176886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
    ; Estcourt LJ; Turgeon AF; McQuilten ZK; McVerry BJ; Al-Beidh F; Annane D; Arabi YM; Arnold DM; Beane A; Bégin P; van Bentum-Puijk W; Berry LR; Bhimani Z; Birchall JE; Bonten MJM; Bradbury CA; Brunkhorst FM; Buxton M; Callum JL; Chassé M; Cheng AC; Cove ME; Daly J; Derde L; Detry MA; De Jong M; Evans A; Fergusson DA; Fish M; Fitzgerald M; Foley C; Goossens H; Gordon AC; Gosbell IB; Green C; Haniffa R; Harvala H; Higgins AM; Hills TE; Hoad VC; Horvat C; Huang DT; Hudson CL; Ichihara N; Laing E; Lamikanra AA; Lamontagne F; Lawler PR; Linstrum K; Litton E; Lorenzi E; MacLennan S; Marshall J; McAuley DF; McDyer JF; McGlothlin A; McGuinness S; Miflin G; Montgomery S; Mouncey PR; Murthy S; Nichol A; Parke R; Parker JC; Priddee N; Purcell DFJ; Reyes LF; Richardson P; Robitaille N; Rowan KM; Rynne J; Saito H; Santos M; Saunders CT; Serpa Neto A; Seymour CW; Silversides JA; Tinmouth AA; Triulzi DJ; Turner AM; van de Veerdonk F; Walsh TS; Wood EM; Berry S; Lewis RJ; Menon DK; McArthur C; Zarychanski R; Angus DC; Webb SA; Roberts DJ; Shankar-Hari M
    JAMA; 2021 Nov; 326(17):1690-1702. PubMed ID: 34606578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
    ; Sadeghipour P; Talasaz AH; Rashidi F; Sharif-Kashani B; Beigmohammadi MT; Farrokhpour M; Sezavar SH; Payandemehr P; Dabbagh A; Moghadam KG; Jamalkhani S; Khalili H; Yadollahzadeh M; Riahi T; Rezaeifar P; Tahamtan O; Matin S; Abedini A; Lookzadeh S; Rahmani H; Zoghi E; Mohammadi K; Sadeghipour P; Abri H; Tabrizi S; Mousavian SM; Shahmirzaei S; Bakhshandeh H; Amin A; Rafiee F; Baghizadeh E; Mohebbi B; Parhizgar SE; Aliannejad R; Eslami V; Kashefizadeh A; Kakavand H; Hosseini SH; Shafaghi S; Ghazi SF; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Piazza G; Kirtane AJ; Van Tassell BW; Dobesh PP; Stone GW; Lip GYH; Krumholz HM; Goldhaber SZ; Bikdeli B
    JAMA; 2021 Apr; 325(16):1620-1630. PubMed ID: 33734299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin in Critically Ill Patients with Covid-19.
    ; Hills TE; Lorenzi E; Berry LR; Shyamsundar M; Al-Beidh F; Annane D; Arabi Y; Aryal D; Au C; Beane A; Bhimani Z; Bonten M; Bradbury CA; Brunkhorst FM; Burrell A; Buxton M; Calfee CS; Cecconi M; Cheng AC; Cove ME; Detry MA; Estcourt LJ; Fitzgerald M; Goligher EC; Goossens H; Green C; Haniffa R; Harrison DA; Hashmi M; Higgins AM; Huang DT; Ichihara N; Jayakumar D; Kruger PS; Lamontagne F; Lampro L; Lawler PR; Marshall JC; Mason AJ; McGlothlin A; McGuinness S; McQuilten ZK; McVerry BJ; Mouncey PR; Murthy S; Neal MD; Nichol AD; O'Kane CM; Parke RL; Parker JC; Rabindrarajan E; Reyes LF; Rowan KM; Saito H; Santos M; Saunders CT; Seymour CW; Shankar-Hari M; Sinha P; Thompson BT; Turgeon AF; Turner AM; van de Veerdonk F; Weis S; Young IS; Zarychanski R; Lewis RJ; McArthur CJ; Angus DC; Berry SM; Derde LPG; Webb SA; Gordon AC; McAuley DF
    N Engl J Med; 2023 Dec; 389(25):2341-2354. PubMed ID: 37888913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.
    ; Gordon AC; Mouncey PR; Al-Beidh F; Rowan KM; Nichol AD; Arabi YM; Annane D; Beane A; van Bentum-Puijk W; Berry LR; Bhimani Z; Bonten MJM; Bradbury CA; Brunkhorst FM; Buzgau A; Cheng AC; Detry MA; Duffy EJ; Estcourt LJ; Fitzgerald M; Goossens H; Haniffa R; Higgins AM; Hills TE; Horvat CM; Lamontagne F; Lawler PR; Leavis HL; Linstrum KM; Litton E; Lorenzi E; Marshall JC; Mayr FB; McAuley DF; McGlothlin A; McGuinness SP; McVerry BJ; Montgomery SK; Morpeth SC; Murthy S; Orr K; Parke RL; Parker JC; Patanwala AE; Pettilä V; Rademaker E; Santos MS; Saunders CT; Seymour CW; Shankar-Hari M; Sligl WI; Turgeon AF; Turner AM; van de Veerdonk FL; Zarychanski R; Green C; Lewis RJ; Angus DC; McArthur CJ; Berry S; Webb SA; Derde LPG
    N Engl J Med; 2021 Apr; 384(16):1491-1502. PubMed ID: 33631065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: a meta-analysis of multicenter randomized controlled trials.
    Pilia E; Belletti A; Fresilli S; Finco G; Landoni G
    J Thromb Thrombolysis; 2022 Oct; 54(3):420-430. PubMed ID: 35922578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
    Spyropoulos AC; Goldin M; Giannis D; Diab W; Wang J; Khanijo S; Mignatti A; Gianos E; Cohen M; Sharifova G; Lund JM; Tafur A; Lewis PA; Cohoon KP; Rahman H; Sison CP; Lesser ML; Ochani K; Agrawal N; Hsia J; Anderson VE; Bonaca M; Halperin JL; Weitz JI;
    JAMA Intern Med; 2021 Dec; 181(12):1612-1620. PubMed ID: 34617959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation Strategies in Non-Critically Ill Patients with Covid-19.
    McQuilten ZK; Venkatesh B; Jha V; Roberts J; Morpeth SC; Totterdell JA; McPhee GM; Abraham J; Bam N; Bandara M; Bangi AK; Barina LA; Basnet BK; Bhally H; Bhusal KR; Bogati U; Bowen AC; Burke AJ; Christopher DJ; Chunilal SD; Cochrane B; Curnow JL; Das SK; Dhungana A; Di Tanna GL; Dotel R; DSouza H; Dummer J; Dutta S; Foo H; Gilbey TL; Giles ML; Goli K; Gordon A; Gyanwali P; Haksar D; Hudson BJ; Jani MK; Jevaji PR; Jhawar S; Jindal A; John MJ; John M; John FB; John O; Jones M; Joshi RD; Kamath P; Kang G; Karki AR; Karmalkar AM; Kaur B; Koganti KC; Koshy JM; Krishnamurthy MS; Lau JS; Lewin SR; Lim LL; Marschner IC; Marsh JA; Maze MJ; McGree JM; McMahon JH; Medcalf RL; Merriman EG; Misal AP; Mora JM; Mudaliar VK; Nguyen V; O'Sullivan MV; Pant S; Pant P; Paterson DL; Price DJ; Rees MA; Robinson JO; Rogers BA; Samuel S; Sasadeusz J; Sharma D; Sharma PK; Shrestha R; Shrestha SK; Shrestha P; Shukla U; Shum O; Sommerville C; Spelman T; Sullivan RP; Thatavarthi U; Tran HA; Trask N; Whitehead CL; Mahar RK; Hammond NE; McFadyen JD; Snelling TL; Davis JS; Denholm JT; Tong SYC
    NEJM Evid; 2023 Feb; 2(2):EVIDoa2200293. PubMed ID: 38320033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 122.